Neuros Medical raises $56m to commercialise nerve stimulation system in US
Neuros Medical has raised $56m in a Series D funding round to support the US commercialisation and further development of …
Neuros Medical has raised $56m in a Series D funding round to support the US commercialisation and further development of …
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) …
ClearNote Health’s Avantect Pancreatic Cancer Test has secured the UK Conformity Assessed (UKCA) marking, signifying compliance with medical device regulations …
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Exactech’s Equinoxe scapula reconstruction system for treating acromial …
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply …
MediView has announced the first patient enrolment in a multi-centre study to assess the procedural efficiency of its XR90 holographic …
French-American spine pain-management surgery specialist Companion Spine has entered a definitive agreement to acquire the Coflex Interlaminar Stabilization device (Corflex), …
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system designed to …
BVI has been recognized with four awards in the 2025 Medical Device Network Excellence Awards for achievements in Innovation, Research …
Ablation therapy treats cancer by applying extreme heat or cold directly to a tumour, destroying malignant cells with unprecedented accuracy. …
CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for patients being …
Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity …
Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR [Bridge-Enhanced ACL Restoration] Implant …
The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse …
US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase …